Search Results 651-660 of 108542 for b-

  1. Publications - William G. Eversman, M.D. - Mayo Clinic

    ... B, Palmieri J, Fraker J, Mina L, Batalini F, Pockaj B. Prospective Study of Supplemental Screening With Contrast-Enhanced Mammography in Women With Elevated ...

  2. Publications - Basar Sareyyupoglu, M.D. - Mayo Clinic

    Paciotti B, Postier JD, Garg P, Lykins A, Sareyyupoglu B. Venoarterial Extracorporeal Membrane Oxygenation and Left Ventricular Decompression Therapy with ...

  3. Medicare - Mayo Clinic

    Medicare Part B (medical insurance) helps to pay for clinic services, doctor fees and outpatient services. If you are unsure whether Medicare is your ...

  4. Mayo Clinic Q and A: Get the Facts Before Taking Folic Acid

    Folic acid is an essential component of prenatal vitamins and typically is included in multivitamin and vitamin B complex supplements. You also can get a ...

  5. Smallpox - Vaccines: Gregory A. Poland, Richard B. Kennedy - Mayo Clinic Research

    The Vaccine Research Group at Mayo Clinic is researching smallpox to better understand the disease and develop effective vaccines.

  6. Meningococcal vaccine (intramuscular route, subcutaneous route) - Side effects & uses - Mayo Clinic

    Bexsero® and Trumenba® is active against group B meningococcal bacteria only. Meningococcal infection can cause life-threatening illnesses, such as ...

  7. Macrocytosis: What causes it? - Mayo Clinic

    Too little vitamin B-12. · Too little vitamin folate. · Liver disease. · Alcohol use. · An underactive thyroid, also called hypothyroidism.

  8. CAR-T cell therapy - Mayo Clinic

    B-cell acute lymphoblastic leukemia. This type of blood cancer is the most common cancer found in children. Chronic lymphocytic leukemia. This leukemia ...

  9. A Study to Evaluate Zanubrutinib to Treat Patients with B-cell Malignancies - Mayo Clinic

    The purpose of this study is to evaluate the long-term safety and effectiveness of zanubrutinib in participants with B-cell malignancies who were previously ...

  10. Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma - Mayo Clinic

    Clinical Trials · Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma · More about research at Mayo ...